impact factor, citescore
logo
 

Full Papers

 

Vitamin D deficiency in connective tissue disease-associated interstitial lung disease


1, 2, 3, 4, 5

 

  1. Department of Rheumatology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  2. Department of Rheumatology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China. tanglin1217@163.com
  3. Department of Rheumatology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  4. Department of Rheumatology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  5. Department of Rheumatology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.

CER10984
2018 Vol.36, N°6
PI 1049, PF 1055
Full Papers

Free to view
(click on article PDF icon to read the article)

PMID: 29846166 [PubMed]

Received: 25/11/2017
Accepted : 12/03/2018
In Press: 24/05/2018
Published: 06/12/2018

Abstract

OBJECTIVES:
To determine and compare the prevalence of vitamin D deficiency in patients with connective tissue disease-associated interstitial lung disease (CTD-ILD). Methods: The level of vitamin D was determined by the serum levels of 1,25(OH)2D3. We evaluated 144 patients in our study, including 53 subjects in the CTD-ILD group and 91 subjects in the CTD group without ILD. CTD was diagnosed following the American College of Rheumatology criteria, and ILD was diagnosed by high-resolution computed tomography. Patients with other known causes of ILD and other pulmonary diseases were excluded. Vitamin D deficiency level was <20 ng/ml. This is a retrospective study.
RESULTS:
Serum vitamin D levels were significantly lower in CTD-ILD patients (p<0.0001). Vitamin D deficiency was lower in the CTD-ILD group (mean±SD: 11.5±4.1 ng/ml) than in the control group (13.9±4.8 ng/ml, p=0.004). The CTD-ILD group was older (p=0.002), had higher levels of fibrinogen (p=0.028) and positive anti-CCP (p=0.026), faster ESR (p=0.001), lower serum levels of serum calcium (p=0.002), and more immunosuppressive therapies (p=0.011). Decreased serum albumin and higher positive antinuclear antibodies (ANA) were associated with reduced vitamin D levels in the vitamin D subgroups. When the odds ratio was adjusted for CTD-ILD, vitamin D deficiency was also a risk factor for CTD-ILD, whereas serum levels of calcium was a protective factor for CTD-ILD.
CONCLUSIONS:
Serum vitamin D deficiency is associated with CTD-ILD and is a risk factor. Therefore, vitamin D may play a role in the pathogenesis of CTD-ILD.

Rheumatology Article